CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Cash Flows from Operating Activities
Net Loss	$ (40,377,160)	$ (17,952,172)	$ (26,476,370)
Non-Cash Adjustments
Depreciation and Amortization	1,870,459	2,458,482	2,441,581
Amortization of Software Development Costs and Prepaid Licenses in Cost of Sales - Products	439,112	183,328	100,000
Stock-Based Compensation	17,302,833	2,805,842	1,498,357
Impairment of Patents and Trademarks	80,163	73,532
Loss on Fixed Asset Disposal	183,614	0	0
Gain on Debt Extinguishment, net of Loss on Note Receivable		(1,305,900)
Inventory Reserve for Obsolescence	519,950	1,273,835	4,572,659
(Increase) Decrease in Operating Assets
Accounts Receivable	(853,547)	(289,413)	(599,577)
Inventories	(6,571,108)	(1,666,792)	(2,998,724)
Manufacturing Vendor Prepayments	(19,019)	(242,493)	512,680
Prepaid Expenses and Other Assets	(526,825)	156,537	414,997
Increase (Decrease) in Operating Liabilities
Accounts Payable	537,607	454,370	(1,605,456)
Accrued Expenses	436,276	97,136	21,819
Customer Deposits			(152,362)
Unearned Revenue	(13,355)	(101,311)	(69,263)
Income and Other Taxes	10,589	90,966	(15,361)
Net Cash Flows Used in Operating Activities	(26,980,411)	(13,964,053)	(22,355,020)
Cash Flows from Investing Activities
Purchases of Fixed Assets	(3,809,268)	(496,629)	(1,898,771)
Investments in Patents and Trademarks	(593,184)	(488,884)	(250,304)
Investments in Licenses, Intangible and Other Assets	(450,000)		(758,464)
Notes Receivable			(250,000)
Investments in Software Development		(500,000)
Net Cash Flows Used in Investing Activities	(4,852,452)	(1,485,513)	(3,157,539)
Cash Flows from Financing Activities
Proceeds from Exercise of Warrants	34,715,728	14,128,527
Proceeds from Exercise of Stock Options	782,277	29,220
Proceeds from Common Stock Offering, Net	91,613,587	25,199,336	18,855,007
Preferred Dividend Settlement Payment	(10,000,000)
Employee Tax Withholdings Payment	(1,144,364)
Proceeds from Term Note		1,555,900
Net Cash Flows Provided from Financing Activities	115,967,228	40,912,983	18,855,007
Net Increase in Cash and Cash Equivalents	84,134,365	25,463,417	(6,657,552)
Cash and Cash Equivalents - Beginning of Period	36,069,508	10,606,091	17,263,643
Cash and Cash Equivalents - End of Period	120,203,873	36,069,508	10,606,091
Supplemental Disclosures
Unamortized Common Stock Expense included in Prepaid Expenses and Other Assets	1,365,242	219,051	83,475
Non-Cash Investment in Licenses	1,294,262	272,444
Stock-Based Compensation Expense - Expensed less Previously Issued	$ (1,127,091)	$ 148,011	$ 93,587